SE0002739D0 - New use - Google Patents
New useInfo
- Publication number
- SE0002739D0 SE0002739D0 SE0002739A SE0002739A SE0002739D0 SE 0002739 D0 SE0002739 D0 SE 0002739D0 SE 0002739 A SE0002739 A SE 0002739A SE 0002739 A SE0002739 A SE 0002739A SE 0002739 D0 SE0002739 D0 SE 0002739D0
- Authority
- SE
- Sweden
- Prior art keywords
- new use
- formula
- treatment
- nhso2
- so2nh
- Prior art date
Links
- 238000011282 treatment Methods 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- -1 aryl sulfonamide compound Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002739A SE0002739D0 (sv) | 2000-07-21 | 2000-07-21 | New use |
CA002411195A CA2411195A1 (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
AU7122501A AU7122501A (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
PCT/SE2001/001652 WO2002008179A1 (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
AU2001271225A AU2001271225B2 (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
EP01950200A EP1301475B1 (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
KR1020087000262A KR100880806B1 (ko) | 2000-07-21 | 2001-07-19 | 비만 치료용 세로토닌 길항제로서 아릴 술폰아미드 |
ES01950200T ES2277930T3 (es) | 2000-07-21 | 2001-07-19 | Aril sulfonamidas como antagonistas de serotonina para el tratamiento de la obesidad. |
NZ523158A NZ523158A (en) | 2000-07-21 | 2001-07-19 | Aryl sulfonamides active as 5-HT6 receptor antagonist or serotonin antagonist for the treatment of obesity |
CNB018131506A CN100339073C (zh) | 2000-07-21 | 2001-07-19 | 作为血清素拮抗剂用于治疗肥胖的芳基磺酰胺 |
DK01950200T DK1301475T3 (da) | 2000-07-21 | 2001-07-19 | Arylsulfonamider, som serotoninantagonist til behandling af obesitet |
PT01950200T PT1301475E (pt) | 2000-07-21 | 2001-07-19 | Arilsulfonamidas como antagonistas da serotonina para o tratamento de obesidade |
JP2002514088A JP2004504377A (ja) | 2000-07-21 | 2001-07-19 | 肥満処置のためのセロトニンアンタゴニストとしてのアリールスルホンアミド |
AT01950200T ATE346040T1 (de) | 2000-07-21 | 2001-07-19 | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit |
DE60124717T DE60124717T2 (de) | 2000-07-21 | 2001-07-19 | Aryl-sulfonamide als serotonin-antagonisten für die behandlung von fettleibigkeit |
KR1020037000687A KR100828977B1 (ko) | 2000-07-21 | 2001-07-19 | 비만 치료용 세로토닌 길항제로서 아릴 술폰아미드 |
US09/908,798 US6399617B1 (en) | 2000-07-21 | 2001-07-20 | Use |
NO20030297A NO20030297D0 (no) | 2000-07-21 | 2003-01-20 | Aryl sulfonamider som serotoninantagonist for behandling av fedme |
HK04100767A HK1057886A1 (en) | 2000-07-21 | 2004-02-06 | Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
CY20071100214T CY1106026T1 (el) | 2000-07-21 | 2007-02-15 | Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002739A SE0002739D0 (sv) | 2000-07-21 | 2000-07-21 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0002739D0 true SE0002739D0 (sv) | 2000-07-21 |
Family
ID=20280564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0002739A SE0002739D0 (sv) | 2000-07-21 | 2000-07-21 | New use |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1301475B1 (sv) |
JP (1) | JP2004504377A (sv) |
KR (2) | KR100880806B1 (sv) |
CN (1) | CN100339073C (sv) |
AT (1) | ATE346040T1 (sv) |
AU (2) | AU2001271225B2 (sv) |
CA (1) | CA2411195A1 (sv) |
CY (1) | CY1106026T1 (sv) |
DE (1) | DE60124717T2 (sv) |
DK (1) | DK1301475T3 (sv) |
ES (1) | ES2277930T3 (sv) |
HK (1) | HK1057886A1 (sv) |
NO (1) | NO20030297D0 (sv) |
NZ (1) | NZ523158A (sv) |
PT (1) | PT1301475E (sv) |
SE (1) | SE0002739D0 (sv) |
WO (1) | WO2002008179A1 (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0204720D0 (en) * | 2002-02-28 | 2002-04-17 | Glaxo Group Ltd | Novel use |
EP1866298A2 (en) | 2005-03-31 | 2007-12-19 | Takeda San Diego, Inc. | Hydroxysteroid dehydrogenase inhibitors |
CL2008003232A1 (es) * | 2007-11-02 | 2009-11-27 | Abbott Gmbh & Co Kg | Compuestos derivados de bencensulfonanilida; composición farmacéutica que los comprende; y uso en el tratamiento de enfermedades del sistema nervioso central, disfunciones cognitivas, esquizofrenia, enfermedades adictivas, enfermedad de alzheimer u obesidad. |
US8343959B2 (en) | 2009-04-30 | 2013-01-01 | Abbott Gmbh & Co. Kg | N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
UA107080C2 (uk) | 2009-04-30 | 2014-11-25 | Сполуки n-феніл(піперазиніл або гомопіперазиніл)бензолсульфонаміду або бензолсульфонілфеніл(піперазину або гомопіперазину), придатні для лікування захворювань, які реагують на модулювання рецептора 5-ht6 серотоніну | |
MX2011011519A (es) * | 2009-04-30 | 2012-01-30 | Abbott Gmbh & Co Kg | Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6. |
CN102459199A (zh) | 2009-04-30 | 2012-05-16 | 雅培股份有限两合公司 | 适于治疗响应于5-羟色胺5-ht6受体调节的病症的苯磺酰苯胺化合物 |
WO2012059432A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor |
WO2012059431A1 (en) | 2010-11-01 | 2012-05-10 | Abbott Gmbh & Co. Kg | Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor |
ES2413911B1 (es) * | 2011-12-15 | 2014-05-14 | Universidad De Zaragoza | Agente inhibidor de la agregación del peptido beta amiloide. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
GB9627006D0 (en) * | 1996-12-27 | 1997-02-12 | Knoll Ag | Therapeutic agents |
CN1087294C (zh) * | 1997-07-11 | 2002-07-10 | 史密丝克莱恩比彻姆有限公司 | 新化合物 |
JPH11171856A (ja) * | 1997-09-26 | 1999-06-29 | Fujirebio Inc | アシルスルホンアミド誘導体 |
GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
-
2000
- 2000-07-21 SE SE0002739A patent/SE0002739D0/sv unknown
-
2001
- 2001-07-19 PT PT01950200T patent/PT1301475E/pt unknown
- 2001-07-19 CA CA002411195A patent/CA2411195A1/en not_active Abandoned
- 2001-07-19 JP JP2002514088A patent/JP2004504377A/ja active Pending
- 2001-07-19 EP EP01950200A patent/EP1301475B1/en not_active Expired - Lifetime
- 2001-07-19 NZ NZ523158A patent/NZ523158A/en unknown
- 2001-07-19 DE DE60124717T patent/DE60124717T2/de not_active Expired - Fee Related
- 2001-07-19 KR KR1020087000262A patent/KR100880806B1/ko not_active IP Right Cessation
- 2001-07-19 KR KR1020037000687A patent/KR100828977B1/ko not_active IP Right Cessation
- 2001-07-19 AU AU2001271225A patent/AU2001271225B2/en not_active Ceased
- 2001-07-19 AU AU7122501A patent/AU7122501A/xx active Pending
- 2001-07-19 AT AT01950200T patent/ATE346040T1/de not_active IP Right Cessation
- 2001-07-19 CN CNB018131506A patent/CN100339073C/zh not_active Expired - Fee Related
- 2001-07-19 ES ES01950200T patent/ES2277930T3/es not_active Expired - Lifetime
- 2001-07-19 WO PCT/SE2001/001652 patent/WO2002008179A1/en active IP Right Grant
- 2001-07-19 DK DK01950200T patent/DK1301475T3/da active
-
2003
- 2003-01-20 NO NO20030297A patent/NO20030297D0/no not_active Application Discontinuation
-
2004
- 2004-02-06 HK HK04100767A patent/HK1057886A1/xx not_active IP Right Cessation
-
2007
- 2007-02-15 CY CY20071100214T patent/CY1106026T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2411195A1 (en) | 2002-01-31 |
DK1301475T3 (da) | 2007-04-02 |
NO20030297L (no) | 2003-01-20 |
ATE346040T1 (de) | 2006-12-15 |
ES2277930T3 (es) | 2007-08-01 |
DE60124717D1 (de) | 2007-01-04 |
NO20030297D0 (no) | 2003-01-20 |
KR100880806B1 (ko) | 2009-01-30 |
CN1443161A (zh) | 2003-09-17 |
CY1106026T1 (el) | 2011-04-06 |
AU7122501A (en) | 2002-02-05 |
EP1301475A1 (en) | 2003-04-16 |
KR20030016413A (ko) | 2003-02-26 |
DE60124717T2 (de) | 2007-09-13 |
KR100828977B1 (ko) | 2008-05-13 |
AU2001271225B2 (en) | 2006-09-07 |
HK1057886A1 (en) | 2004-04-23 |
NZ523158A (en) | 2004-04-30 |
KR20080016725A (ko) | 2008-02-21 |
CN100339073C (zh) | 2007-09-26 |
WO2002008179A1 (en) | 2002-01-31 |
PT1301475E (pt) | 2007-02-28 |
EP1301475B1 (en) | 2006-11-22 |
JP2004504377A (ja) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
NO20083207L (no) | Inhibitorer av IAP | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
DE50310516D1 (de) | Fredericamycin-derivate | |
CY1105915T1 (el) | Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar | |
CY1108267T1 (el) | Ενωσεις που επηρεαζουν τη γλυκοκιναση | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
CY1106026T1 (el) | Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
DE60232173D1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
NO20054361D0 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte | |
DK1558580T3 (da) | N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner | |
SE0004101D0 (sv) | New use | |
NO20030500D0 (no) | Dihydroporfyrinderivater og deres anvendelse | |
SE0200198D0 (sv) | New use | |
CY1106576T1 (el) | Υποκατεστημενα παραγωγα 2-πυρρολιδιν-2-υλ-1h-ινδολης για τη θεραπεια ημικρανιας | |
ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
DE60120398D1 (de) | Imidazopyridin-8-one | |
DE10293089D2 (de) | Phosphinat-peptidanaloga als Inhibitoren der Procollagen-C-Proteinase (PCP) zur Behandlung von fibrotischen Erkrankungen | |
BR0317413A (pt) | Uso de tiazolobenzoheterociclos para o tratamento de esclerose múltipla | |
NO20070058L (no) | Amino-halogen-imidazopyridiner som protonpumpeinhibitorer | |
SE0202287D0 (sv) | New compounds | |
EA200500903A1 (ru) | Силиловые простые эфиры |